Antimicrobial drug development – the past, the present, and the future

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

The greatest steps towards the discovery of Vibrio cholerae

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Nocardiosis in Quebec, Canada, 1988–2008

Louis Pasteur, from crystals of life to vaccination

Antibacterial drug discovery: is it all downhill from here?

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

Training for the infectious diseases speciality in Norway

B. Gordts Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Laboratory diagnosis of Clostridium difficile disease

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Current experience in treating invasive zygomycosis with posaconazole

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

A.P. Underwood, J. Green Clinical Microbiology and Infection

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

V. Vlahović-Palčevski, U. Dumpis, P. Mitt, J. Gulbinovič, J. Struwe, G

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis Bernard Grenier Clinical.

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Antimicrobial drug development – the past, the present, and the future J.H. Powers Clinical Microbiology and Infection Volume 10, Pages 23-31 (January 2004) DOI: 10.1111/j.1465-0691.2004.1007.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Drug approvals by class: systemic antibacterials. Clinical Microbiology and Infection 2004 10, 23-31DOI: (10.1111/j.1465-0691.2004.1007.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Ten year trend in drug and biological new molecular entity (NME) submissions to FDA. (from Reference 5) Clinical Microbiology and Infection 2004 10, 23-31DOI: (10.1111/j.1465-0691.2004.1007.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Ten-year trend in biomedical research spending. (from Ref. 5) Clinical Microbiology and Infection 2004 10, 23-31DOI: (10.1111/j.1465-0691.2004.1007.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 4 Drug approvals by class: systemic antivirals. Clinical Microbiology and Infection 2004 10, 23-31DOI: (10.1111/j.1465-0691.2004.1007.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions